The ten mistakes that cost first-cycle users the most, why each one happens physiologically, and what the evidence says about bloodwork, estrogen and recovery.
25 min read
Most first-cycle damage is not caused by the compound. It is caused by decisions made without data: no baseline labs, numbers copied off a forum, estrogen managed by guesswork, and no plan for the day the gear stops. This guide works through the ten mistakes that show up most often, explains the physiology behind each one, and reviews the advice from its own first edition against the published evidence, correcting it where the two disagree.
What's Inside
Written for anyone considering or already on a first cycle who wants the physiology and the evidence rather than forum consensus, and for coaches who field these questions. It assumes you intend to run bloodwork before, during and after, and that a clinician is involved. It is harm reduction, not encouragement, and it is explicit that no randomised trial has ever tested a first-cycle structure, a post-cycle protocol or a support stack in non-medical users.
Mostly the absence of a baseline. Without one, every number on cycle is uninterpretable: an ALT of 70 could be the oral, it could be yesterday's leg session, or it could simply be your normal, and you only know which if you tested before you started. That matters more than most beginners expect, because four of the markers people rely on are easy to misread. Skeletal muscle releases both AST and ALT, so a hard session in the days before a draw can mimic liver injury, which is why ALT and AST belong next to GGT and CK rather than being read alone. Creatinine scales with muscle mass and creatine intake, so creatinine-based eGFR understates kidney function in muscular men and cystatin C is the more reliable confirmation. Routine estradiol immunoassays overestimate low male values, so a sensitive assay is the one worth paying for. And hematocrit is hydration-sensitive, so a dehydrated draw inflates it. Underneath all of it sits the mechanism nobody can opt out of: exogenous androgens and the estradiol made from them tell the hypothalamus and pituitary there is already plenty of hormone, GnRH and LH or FSH output falls, and serum testosterone reads high while intratesticular testosterone and sperm production drop. Every cycle is therefore also a shutdown, and recovery is a separate project with its own timeline. Build the panel with the Blood Test Selector and read it with the Bloodwork Analyzer.
Because it is the only version that teaches you anything. Stack three compounds, get a side effect, and you cannot tell which one caused it. Testosterone alone gives you your own map: your estradiol sensitivity, your hematocrit response, your blood pressure response, your skin and your hair. Every later decision is built on that map. The two popular alternatives both fail for physiological reasons rather than ideological ones. Oral-only cycles look milder because there is no needle, and are the opposite: 17α-alkylated compounds are built to survive first-pass metabolism, which is exactly what loads the hepatocyte and raises cholestasis risk, and the same structure up-regulates hepatic lipase, which clears HDL and produces the steepest HDL fall of any option. Dianabol aromatizes to a potent methylated estrogen, while Anavar does not aromatize at all, which leaves a low testosterone plus low estradiol state that shows up as flat libido, sore joints and poor mood. Harsh compounds fail for a different reason: trenbolone is a veterinary drug whose human evidence is case reports and user surveys, oxymetholone is approved for anemias of deficient red cell production, which is precisely why hematocrit climbs on it, and methasterone has published case series of severe cholestatic liver injury. On dose, the trial that compared several dose levels of testosterone in healthy men found lean mass and strength rose with dose, and so did hemoglobin, while HDL fell with dose. There was no level at which the benefit continued without the cost. Estrogen is the mistake that runs in both directions, since the controlled trial that fixed testosterone and blocked aromatization saw men lose libido and erectile function and gain body fat, which makes a crashed estradiol its own injury rather than a safe default. Model it with the Estrogen and AI tool and check a lump with the Gyno Assessment.
It does not restore anything by itself. It shortens the low testosterone window by pushing the hypothalamus and pituitary to restart LH and FSH while your own axis wakes up, which means getting the logic wrong extends the crash instead of shortening it. Three corrections matter here. First, hCG is an LH analogue acting directly on the Leydig cell, so it keeps the testes working while the axis above them stays switched off, and the testosterone and estradiol it generates are what keep pituitary LH and FSH suppressed. That is why hCG on its own cannot restart the axis, and the earlier edition had the mechanism backwards. Second, no randomised trial has tested any post-cycle protocol in people using these compounds non-medically, so SERM use here is off-label extrapolation from hypogonadism and infertility practice rather than evidence. Third, running two SERMs together is redundant, since both block estrogen receptors at the hypothalamus and nothing shows an additive benefit over one agent, and both carry warnings worth respecting: clomiphene can cause visual disturbances, which is a stop-and-do-not-restart signal, and tamoxifen carries a venous clot warning that matters more if hematocrit ran high on cycle. The recovery picture itself is better than the forums suggest and worse than the sales pitch: most men recover, pooled contraception trials put sperm recovery around two thirds at six months and near complete by two years, but persistent low testosterone years after stopping is documented in former users, and longer, heavier and repeated cycles raise that risk. Recovered means LH and FSH back in range, total testosterone back in your own pre-cycle range, off every drug, with libido, mood and morning erections normal. Plan it with the PCT and Recovery Protocol Builder and compare the options in HCG and HMG vs SERMs.
Training and food, then the exit. Androgens amplify the signal from training and diet, they do not create it: in the controlled trial, testosterone plus structured training added roughly 6.1 kg of fat-free mass against roughly 1.9 kg from training alone, so the drug multiplied the training rather than replacing it. The exit itself is where the first edition needed the biggest correction. The old advice was to taper training intensity after the last injection, and the evidence says the reverse: muscle size is maintained on a fraction of the original training volume as long as intensity stays high, so cut volume and keep the load, because dropping intensity is what loses muscle. A calorie deficit stacked on top of low testosterone is the fastest route to muscle loss, which is why maintenance or slightly above holds until recovery labs come back, and the scale drop in the first weeks is mostly water and glycogen rather than tissue. Judge it by strength and tape measurements. On-cycle support is worth having and is not a shield: no supplement makes a dose safe, an androgen-driven HDL drop does not respond meaningfully to supplements when the real levers are removing the oral and lowering the dose, and hematocrit is managed with dose, hydration and clinical decisions rather than pills. Support earns its place when it targets a marker your labs show is actually moving. A few things are same-day medical review rather than something to manage: spreading redness, heat or fever around an injection site, an urge to cough or chest tightness in the minutes after an oil injection, and chest pain, breathlessness, one-sided weakness or calf swelling at any point. Low mood after a cycle is common and real, and is worth telling someone about. Set the training inputs with the Protein Calculator, and if injections are the problem, Fix Post Injection Pain covers that in full.
The full guide covers all ten mistakes in order, the three-phase bloodwork panel with every marker and the do-not-start thresholds, the HPG axis diagram, the dose-response evidence review, the complete post-cycle timeline and protocol with its evidence grading, the injection technique rules, the on-cycle support table with what each item is monitored by, the action thresholds for every marker, and a symptom-to-cause troubleshooting framework. Download the PDF for the complete reference.
This page and the full guide are for educational purposes only. They are not medical advice and do not endorse or encourage the use of anabolic steroids, prescription drugs or performance-enhancing substances. Possession, sale and use of these compounds may be illegal in your jurisdiction and are prohibited in sport under the WADA Code. Every drug named here, including aromatase inhibitors, SERMs, hCG and blood pressure medication, requires a prescriber. Use can cause cardiovascular disease, high blood pressure, adverse lipids, testosterone suppression, infertility, gynecomastia, liver and kidney toxicity, mood disorders, dependence, hair loss and acne. Adults 18 and over only. Do not start, stop or change anything without a qualified clinician.
Running one compound is the only way to learn your own estradiol, hematocrit, blood pressure and hair response without confounders. Stack three and a side effect has no traceable cause.
No. 17α-alkylated orals load the liver and produce the steepest HDL fall, while still shutting down your own testosterone without replacing what it does systemically.
No. hCG acts on the testes as an LH analogue, so the axis above them stays switched off, and the testosterone and estradiol it generates keep LH and FSH suppressed.
Skeletal muscle releases ALT and AST, so hard training before a draw can mimic liver injury. High CK with a normal GGT points to muscle rather than the liver.
This guide is for educational purposes only and is not medical advice.
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.
